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Abstract
Background: The study aimed at (i) characterizing the mode of transmission of blaCTX-M and blaTEM-1 among
extended-spectrum-b-lactamase (ESBL)-producing Escherichia coli strains isolated from infected diabetic foot ulcers,
and (ii) identifying the risk factors for “sex-associated multidrug resistant Gram-negative bacterial (MDRGNB)-
infection status” of the ulcers.
Methods: Seventy-seven diabetic patients having clinically infected foot ulcers were studied in a consecutive
series. The E. coli strains isolated from the ulcers were screened for blaCTX-M, blaTEM-1, armA, rmtA and rmtB during
the 2-year study-period. PCR amplified blaCTX-M genes were cloned and sequenced. Enterobacterial repetitive
intergenic consensus (ERIC)-PCR was used for the analysis of genetic relatedness of the ESBL-producers. Risk factors
for “sex-associated MDRGNB-infection status” of ulcers were assessed. Modeling was performed using Swiss-Model-
Server and verified by Procheck and verify3D programmes. Discovery Studio2.0 (Accelrys) was used to prepare
Ramachandran plots. Z-scores were calculated using ‘WHAT IF’-package. Docking of cefotaxime with modeled CTX-
M-15 enzyme was performed using Hex5.1.
Results: Among 51 E. coli isolates, 14 (27.5%) ESBL-producers were identified. Only 7 Class1 integrons, 2 blaCTX-M-15,
and 1 blaTEM-1 were detected. Ceftazidime and cefotaxime resistance markers were present on the plasmidic DNA
of both the blaCTX-M-15 positive strains and were transmissible through conjugation. The residues Asn132, Glu166,
Pro167, Val172, Lys234 and Thr235 of CTX-M-15 were found to make important contacts with cefotaxime in the
docked-complex. Multivariate analysis proved ‘Glycemic control at discharge’ as the single independent risk factor.
Conclusions: Male diabetic patients with MDRGNB-infected foot ulcers have poor glycemic control and hence
they might have higher mortality rates compared to their female counterparts. Plasmid-mediated conjugal transfer,
albeit at a low frequency might be the possible mechanism of transfer of blaCTX-M-15 resistance marker in the
present setting. Since the docking results proved that the amino acid residues Asn132, Glu166, Pro167, Val172,
Lys234 and Thr235 of CTX-M-15 (enzyme) make important contacts with cefotaxime (drug) in the ‘enzyme-drug
complex’, researchers are expected to duly utilize this information for designing more potent and versatile CTX-M-
inhibitors.
Background
Multidrug resistant Gram-negative bacteria (MDRGNB)
are a major therapeutic challenge both in hospital and
community settings [1]. We have recently reported a
high prevalence of extended-spectrum beta lactamase
(ESBL)-producing bacteria in the neonatal intensive care
unit of Aligarh hospital, India [2]. ESBLs are often plas-
mid-associated and there can be cross-species dissemi-
nation of these plasmids. Moreover, these plasmids
often carry genes for co-resistance to other antibiotics
such as aminoglycosides, fluoroquinolones, tetracyclines,
chloramphenicol and sulfamethoxazole-trimethoprim.
Concomitant b-lactam and aminoglycoside resistance
involving armA and rmtB g e n e si si n c r e a s i n g l yb e i n g
reported [3].
Foot ulcers are a very common complication of type 1
and type 2 diabetes. The Indian diabetic population is
expected to increase to 57 million by 2025 [4]. Indivi-
duals with diabetes have at least a 10-fold greater risk of
being hospitalized for soft tissue and bone infections of
the foot than the individuals without diabetes [5].
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in diabetic patients have been described frequently [6].
Due to non-use of standard microbiological techniques,
there is a paucity of ESBL data concerning diabetic foot
ulcers particularly in India.
CTX-Ms have become the most prevalent ESBLs
worldwide. It is of due importance to know the amino
acid residues crucial to the interaction between cefotax-
ime and CTX-M-15, as this enzyme is increasingly
being reported from this part of the world together with
TEM-1 [7]. Moreover, Escherichea coli is one of the
most common infecting organisms isolated from soft tis-
sue infections [8]. Accordingly we looked for the mode
of transmission of blaCTX-M and blaTEM-1 resistance
markers among the E. coli strains isolated from infected
foot ulcers of diabetic patients admitted to the endocri-
nology ward of the Aligarh hospital. The study aimed at
(i) characterizing the mode of transmission of blaCTX-M
and blaTEM-1 among ESBL-producing E. coli strains iso-
lated from infected diabetic foot ulcers, and (ii) identify-
ing the risk factors for “sex-associated MDRGNB
infection status” of the ulcers.
Methods
Collection of bacterial strains and patients’ details
The study was conducted at Aligarh hospital, India
(from April 2007 to November 2008). Seventy-seven dia-
betic patients having clinically infected foot ulcers
admitted to the endocrinology ward were studied in a
consecutive series. Wagner classification was employed
to grade the ulcers [9]. Thirty-two study factors were
recorded for each patient. BMI i.e. Body Mass Index (<
18.5 kg/m
2 = underweight; 18.5-22.9 kg/m
2 =n o r m a l
weight; 23.0- 24.9 kg/m
2 = overweight), presence of
nephropathy (creatinine ≥ 150 μmol/l or presence of
micro- or macroalbuminuria), neuropathy (absence of
perception of the Semmes-Weinstein monofilament at 2
of 10 standardized plantar sites on either foot) and per-
ipheral vascular disease (ischemic symptoms and inter-
mittent claudication or rest pain, with or without
absence of pedal pulses), were some of them. Osteomye-
litis was diagnosed on suggestive changes in the radio-
graphs and bone scans. Regarding a fasting blood
glucose level of < 110 mg/dl and/or postprandial level of
< 160 mg/dl as glycemic control, the number of patients
achieving glycemic control over the hospital stay was
compared with respect to sex. In case a patient had
multiple ulcers, specimens from all the ulcers were
taken. If any of the ulcers was found to be infected with
MDRGNB, the patient was grouped in the MDRGNB-
infected category. Fasting HDL and VLDL were mea-
sured and LDL was calculated by subtracting their sum
from total cholesterol. Clinical assessment for signs of
infection (swelling, exudate, surrounding cellulitis, odor,
tissue necrosis, crepitation, and pyrexia) was made.
Ulcer size was determined by multiplying the longest
a n dw i d e s td i a m e t e r sa n de x p r e s s e di nc e n t i m e t e r s
squared. Demographic and other relevant details were
retrieved from medical records.
Microbiological methods
Culture specimens were obtained at the time of admis-
sion, after the surface of the wound had been washed
vigorously by saline, and followed by debridement of
superficial exudates. Specimens were obtained by scrap-
ing the ulcer base or the deep portion of the wound
edge with a sterile curette. The soft tissue specimens
were quickly sent to the laboratory and processed for
Gram-negative bacteria. Standard methods for isolation
and identification of bacteria were used [10]. Antimicro-
bial susceptibility testing of the isolates was performed
by the standard disc diffusion method as recommended
by the Clinical and Laboratory Standards Institute
(CLSI) [11]. The test-antibiotics included gentamycin,
tobramycin, amikacin, kanamycin, streptomycin, cefa-
lothin, cefazolin, cefuroxime, cefoxitin, ceftazidime, cefo-
taxime, ceftriaxone, cefepime, ciprofloxacin, norfloxacin,
tetracycline, piperacillin, imipenem as well as combina-
tions such as amoxyclav and piperacillin/tazobactam.
Minimum Inhibitory Concentrations (MICs) for the
same antimicrobials were determined by the CLSI
microbroth dilution method [11]. The ESBL synergy test
for the study isolates was performed as described by Jar-
lier et al [12]. For this study, bacteria resistant to at
least 4 of the test antibiotics were designated as
MDRGNB. All ESBL-producers were considered as
MDRGNB.
Molecular typing and PCR
Enterobacterial repetitive intergenic consensus (ERIC)-
PCR was used for the analysis of genetic relatedness of
the ESBL-producers as described elsewhere [13]. A
search for blaCTX-M, blaTEM-1, armA, rmtA and rmtB
genes in the genomic and plasmidic DNA of isolates
which were positive for ESBL synergy test was per-
formed by PCR amplification, as described previously
[14-16]. Plasmids were obtained by the method of Kado
and Liu [17]. Screening of integrons was also performed
as described elsewhere [18].
Cloning and sequencing
PCR amplified blaCTX-M genes, were ligated into
‘pDrive-easy-PCR-cloning-vector’ and transformed into
competent E. coli C600 cells using Qiagen Cloningplus
Kit (Qiagen, USA). Transformed colonies were selected
on Luria-Bertani agar plates, containing isopropyl-b-D-
thiogalactopyranoside (1 mM), 5-bromo-4-chloro-3-
indolyl-b-D-thiogalactopyranoside (40 mg/L) and kana-
mycin (30 mg/L). Plasmid extracted from the culture of
a well-isolated white colony was used as template for
PCR amplifications of blaCTX-M.T h es a m ep l a s m i d s
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cells. The transformants were selected on Luria-Bertani
agar plates containing azide (250 mg/L), cefotaxime (2
mg/L) and kanamycin (30 mg/L). The transformed cells
were re-checked for ESBL-production. DNA sequences
were analyzed with ABI 3130 Genetic Analyzer (Applied
Biosystems). The Basic Local Alignment Search Tool
(BLAST) program of the National Center for Biotech-
nology Information http://www.ncbi.nlm.nih.gov was
used to search databases for similar nucleotide
sequences.
Marker transfer experiments
E. coli strains that were PCR-positive for any of the
tested genes were used as donors in transconjugation
experiments as described elsewhere [20]. Azide-resistant
E. coli J53 was used as the recipient. Transconjugants
were selected on Luria-Bertani agar plates containing
azide (250 mg/L) and either cefotaxime (2 mg/L) or
gentamicin (50 mg/L).
Statistical analysis
Qualitative variables were expressed as percentages and
quantitative variables were expressed as means ± SD
(Standard Deviation). Significance of the study variables
for “sex-associated MDRGNB infection status” of the
foot ulcers was tested by using Student’s t test or Fish-
er’s exact test as appropriate. All risk factors that proved
to be statistically significant on univariate analysis were
entered by blockwise entry in a logistic regression
model after exclusion of multicollinearity and interac-
tion between variables. A two-tailed p value of < 0.05
was taken as significant. Statistical analysis was per-
formed using SPSS (version 11.5, Chicago). The results
were again confirmed using the SISA (Simple Interactive
Statistical Analysis) program http://www.quantitatives-
kills.com/sisa/distributions/binomial.htm
Homology Modeling and Docking
BLAST-P was performed to retrieve suitable templates
for homology-modeling using the blaCTX-M sequences
obtained in this study. Protein Data Bank (PDB) IDs of
these templates are shown in table 1. Models were pre-
pared using Swiss-Model-Server [21] and verified by
Procheck [22] and verify3D programmes [23]. Discovery
Studio2.0 (Accelrys) was used to prepare Ramachandran
plots. Z-scores were calculated using ‘WHAT IF’-pack-
age. Cefotaxime was docked into each of the modeled
structures employing Hex 5.1.
Results
General results
A total of 185 Gram-negative bacteria were isolated
from 95 foot ulcer samples of the 77 diabetic patients
admitted during the study-period. Out of these bacteria,
149 (80.5%) were found to be MDRGNB. Sixty-six sam-
ples which belonged to 55 patients were found to harbor
these MDRGNB. Fig 1 shows the distribution of
MDRGNB obtained from infected diabetic foot ulcers
divided into 2-month periods from April 2007 to
November 2008. Characteristics of male and female
patients having MDRGNB-infected foot ulcers were
recorded. Among the 55 MDRGNB-infected patients, 46
(83.6%) were males while 9 (16.4%) were females.
Grade-5 ulcer was found in 1 male patient only. The
majority of subjects (89.1%) had type 2 diabetes. Fifty-
one (92.7%) were hypertensive, 22 (40%) had retinopa-
thy, 37 (67.3%) had nephropathy, 34 (61.8%) had neuro-
pathy and 33 (60%) had peripheral vascular disease.
Nine (16.4%) patients had osteomyelitis. Three male
patients died during the hospital stay. However, there
were only 2 subjects who possessed foot ulcer infected
with more than 1 ESBL-producing strain.
Antimicrobial susceptibility and ESBL-production
Forty-three (28.9%) ESBL-producers were identified
among the 149 MDRGNB. The highest ESBL produc-
tion was noted in Pseudomonas aeruginosa (20/61;
32.8%), followed by E. coli (14/51; 27.5%) and K. pneu-
moniae (9/38; 23.7%). All the MDRGNB showed 100%
susceptibility to imipenem (data not shown). All the
ESBL-producers, with the exception of P. aeruginosa
strains were found to be susceptible to cefoxitin, imipe-
nem and piperacillin/tazobactam while the same were
resistant to ceftazidime, cefotaxime and piperacillin.
However, the ESBL producing strains of P. aeruginosa
were invariably resistant to cefoxitin. Amikacin was the
most effective of all the aminoglycosides against ESBL-
producers. Imipenem alone and the piperacillin/
Table 1 Analysis of blaCTX-M-15 markers using bioinfor-
matic approach and clinical profile
CTX-M-15 positive E. coli strain D253 D281
ERIC profile M1 M1
Class1 integron + +
int1 ++
sul1 ++
Sampling date 8/4/2008 14/6/2008
Sex of the patient Female Male
Accession no. of reference strain used
for alignments
FJ668785 FJ668753
#PDB ID of the template retrieved for
modeling
1iysA 1iysA
Cefotaxime MIC of the strain (mg/L) 256 64
Ceftazidime MIC of the strain (mg/L) 32 32
*E-total (Kj/mol) -221.51 -168.17
*E-shape (Kj/mol) -208 -147.5
*E-force (Kj/mol) -13.51 -20.67
Genbank accession numbers (This
study)
FJ997866 GQ145220
#PDB = Protein Data Bank
*E = Binding energy with cefotaxime
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of choice. Hence, the 43 ESBL-producers could be
broadly divided into 3 different resistance patterns.
Strains resistant to aminoglycosides and quinolones but
susceptible to cefepime constituted pattern 1. Pattern 2
comprised of strains resistant to cefepime but suscepti-
ble to either aminoglycosides or quinolones or both.
Strains resistant to all the three mentioned classes of
antibiotics constituted pattern 3. Resistance pattern 1
was found to be the most common among ESBL-produ-
cers. The other aerobic Gram-negative organisms iso-
l a t e df r o mf o o tu l c e r si n c l u d e dAcinetobacter
baumannii (5 strains), Proteus species (20 strains),
Enterobacter species (1 strain) and Morganella morganii
(1 strain). None of these were ESBL-producers. Only 13
anaerobes were isolated of which 8 were Gram-negative.
The Gram-negative anaerobes consisted of Veillonella
species (3 strains) and Bacteroides species (5 strains)
none of which happened to be MDRGNB.
PCR amplifications, cloning and sequencing of blaCTX-M-15
Only 2 strains were confirmed to harbor blaCTX-M by
PCR. Strain D253 was positive for both blaCTX-M and
blaTEM-1 while strain D281 possessed only blaCTX-M.
None of the strains were positive for any of the 16S
rRNA methyl transferase genes (i.e. armA, rmtA or
rmtB). Seven integrons were detected whose sizes ranged
from 600 bp to 1.5 Kb. All these integrons were found to
be Class1 type and were positive for int1 and sul1 genes
of the expected sizes 845 bp and 840 bp respectively.
None of the genes were located in the integrons. E. coli
C600 cells harboring cloned blaCTX-M (C600
blaCTX-M)
were again found to be PCR-positive for the said gene in
all instances. Moreover, cultures derived from C600
blaCTX-M c e l l sg a v eap o s i t i v eE S B Ls y n e r g yt e s t .A z i d e
resistant E. coli J53 cells transformed with the plasmidic
DNA extracted from C600
blaCTX-M cells became cefotax-
ime resistant. Also, cultures derived from these trans-
formed E. coli J53 cells were found to be positive for the
ESBL test. Sequencing results confirmed all the blaCTX-M
genes obtained in this study as blaCTX-M-15.
Plasmid mediated marker transfer and molecular typing
The ceftazidime and cefotaxime resistance markers were
located on the plasmidic DNA of both the blaCTX-M-15
positive strains and were transmissible through conjuga-
tion. Quinolone (ciprofloxacin) resistance was co-trans-
ferred with cefotaxime resistance, in only one of the
blaCTX-M-15 positive isolates. Transfer frequencies (Total
no. of transconjugants per plate/Total no. of recepients
per plate) observed were of the order 10
-5 (Table 2).
Randomly taking a single representative strain in case of
identical susceptibility patterns, ERIC-PCR was per-
formed for 40 ESBL-producers. P. aeruginosa, K. pneu-
moniae and E. coli displayed 5, 5 and 8 major ERIC-
profiles respectively (Fig 2). Both the blaCTX-M-15 posi-
tive strains were found to be clonally related and dis-
played ERIC-profile M1 (Table 1).
Figure 1 Distribution of multidrug resistant Gram-negative bacteria obtained from infected diabetic foot ulcers divided into 2-month
periods from April 2007 to November 2008.
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Over 90% of the amino acid residues in the protein
structures modeled from blaCTX-M-15 genes obtained in
this study were found to be present in the most favor-
able regions as revealed by their respective Ramachan-
dran plots. The Ramachandran Z-score for modeled
enzyme from strain D253 was found to be 0.027 (Fig
3a), which further confirms the accuracy of the modeled
structure. Cefotaxime was docked into the modeled
enzyme-structures. It was found that the strain (D253)
having a higher cefotaxime MIC displayed a higher
negative binding energy as well (Table 1). Analysis of
the docked structures by Discovery Studio2.0 revealed
that the amino acid residues Asn132, Glu166, Pro167,
Val172, Lys234 and Thr235 make important contacts
with cefotaxime (Fig 3b).
Risk factor analysis
In the univariate analysis, many study variables includ-
ing mean age, mean ulcer duration, smoking, Wagner
grade and ‘glycemic control at discharge’ (all p = 0.00)
were found to be significant for “sex-associated
MDRGNB infection status” of the foot ulcers. Hence, we
went for multivariate analysis. The multiple logistic
regression model confirmed ‘glycemic control at dis-
charge’ to be the single independent risk factor for the
same. (p = 0.001). ORs and 95% CIs can be seen in
Additional file 1. Hence our main finding is that, male
diabetic patients having MDRGNB-infected foot ulcers
have poor glycemic control during the hospital stay.
Nucleotide sequence accession numbers
The accession numbers of the E. coli genes sequenced in
this study are [GenBank: FJ997866], [GenBank:
FJ997867] and [GenBank: GQ145220].
Discussion
This is the first study to report on risk factors for “sex-
associated MDRGNB-infection status” of diabetic foot
ulcers from this region of India (Uttar Pradesh). We do
not claim that these 77 patients represent the entire
region. Hence, similar studies from this region and
across the globe that could help in updating the empiri-
cal antibiotic regimen in diabetic foot ulcers are highly
recommended. We regret that we could not use bone
biopsy sample in case of osteomyelitis. Bone biopsy may
be traumatic to patient and is not routinely performed
in our hospital. Moreover, Pellizzer et al. [24] have
reported that samples taken from the base of the wound
after debridgement are adequate to identify the infecting
organism, which we needed. Infections due to multidrug
resistant organisms in hospitalized patients with diabetic
foot ulcers have been reported previously [25]. Com-
pared with earlier reports, we recovered fewer anaerobic
species [26]. Our patients did not have chronic draining
wounds, and very few had gangrene associated with
their infections. This may be an indication of fewer
anaerobic species among nonthreatening lower-extre-
mity infections, which has been reported earlier [27].
Patients with diabetic foot ulcers whose blood glucose
levels are poorly controlled exhibit higher mortality
rates [28]. Our results indicate that male diabetic
patients with MDRGNB-infected foot ulcers have poor
glycemic control. Hence, male diabetic patients having
MDRGNB-infected foot ulcers might have higher mor-
tality than their female counterparts. Studies have
reported ‘male sex’ as a significant risk factor for non-
healing foot ulcers [29]. In a study by Basit et al. [30]
hypertension was found to be significantly associated
with poor glycemic control (OR = 1.65). Also, in a study
by Minh et al. [31], the prevalence of hypertension was
found to be significantly higher among men than
Table 2 Transconjugation frequencies, resistance markers
transferred to recipient strains and MICs of antibiotics
used against blaCTX-M-15 positive strains of E. coli
Name of the strain D253 D281
MIC (mg/L) 00
Gentamicin (G) 128 64
Tobramycin (Tb) 64 32
Kanamycin (Ka) 64 128
Amikacin (Ak) 32 32
Streptomycin (St) 64 64
Cefazolin (Cz) >256 >256
Ceftazidime (Ca) 32 32
Cefotaxime (Ce) 256 64
Ceftriaxone (Ci) 256 512
Cefepime (Cpm) 64 64
Ciprofloxacin (Cf) 64 64
Norfloxacin (Nx) 64 32
Piperacillin (Pc) >256 512
Amoxyclav (Ac) 4 2
Tetracycline (T) 256 512
Resistance pattern
type
33
Resistance markers
present in donor or
test isolates
G, Tb, Ka, St, Ch, Cz,
Cu, Ca, T, Ce, Ci, Cpm,
Cf, Nx, Pc
G, Tb, Ka, St, Ch, Cz,
Cu, Ca, T, Ce, Ci, Cpm,
Cf, Nx, Pc
Resistance markers
transferred to the
recipient (E. coliJ53)
Ca, Ce, Ci, T Ca, Ce, Ci, Cf
Total no. of
transconjugants per
plate
1.7 × 10
2 2.1 × 10
2
Total no. of recepients
(E. coliJ53) per plate
10
7 10
7
Tansfer Frequency
(Total No. of
transconjugants per
plate/Total no. of
recepients per plate)
1.7 × 10
-5 2.1 × 10
-5
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hypertension as a baseline (OR = 1.00), presence of
hypertension with a presence of ‘glycemic control at dis-
charge’ showed an OR of 0.375 while the same with an
absence of ‘glycemic control at discharge’ showed an
OR of 18.0. Hence, an absence of glycemic control with
the presence of hypertension appears to be a strong
indicator of MDRGNB-infections in male diabetic
patients.
A surveillance program reported the frequency of
ESBL-producing K. pneumoniae to be approximately
37% in Latin America vs. 7% in the United States [32].
Plasmid mediated blaCTX-M-15 among clinical isolates
have also been reported earlier [33]. Only 2 of our 43
ESBL-producing strains were PCR-positive for blaCTX-M-
15. This is in harmony with a study in which the authors
detected only 3 strains out of 365 clinical isolates that
were PCR-positive for blaCTX-M-15 [ 3 4 ] .H o w e v e r ,t h i s
Figure 2 ERIC-profiles of extended-spectrum b-lactamase producing bacteria isolated from infected foot ulcers of diabetic patients. ‘M’
stands for marker (the first lane of each figure).
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Page 6 of 10Figure 3 (a) CTX-M-15 enzyme modeled from the blaCTX-M-15 gene sequence [Genbank: FJ997866] of E. coli strain D253.T h ea c t i v es i t e
Ω-loop, the SDN loop and the KTG motif are labeled. A = 91.5%, B = 7.8%, C = 0.7%, D = 0.0%, where ‘A’, ‘B’, ‘C’ and ‘D’ stand for percent amino
acid residues in most favored, additional allowed, generously allowed and disallowed regions of the Ramachandran plot respectively. The z-score
for the modeled structure was equal to 0.027. (b) Amino acid residues crucial to the interaction between cefotaxime and CTX-M-15.
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reported a high prevalence of blaCTX-M-15 among clinical
isolates [35]. ESBL-production in the remaining ESBL-
positive strains might be due to ESBL-types other than
CTX-Ms such as SHV/OXA/TEM/GES/BES/PER/TLA/
IBC etc. as each of these have many variants. A high
prevalence of ESBL-producers was observed in strains of
P. aeruginosa (32.8%), which is generally considered to be
a rare ESBL-producer. This result was in harmony with
the reports from Peshawar, Pakistan (close to North
India) and even Delhi (India) which is adjacent to Ali-
garh. The authors of these studies have reported 35.85%
and 33.6% ESBL-producers among P. aeruginosa isolates,
respectively [36,37]. However, since the sample sizes were
not large, we prefer to conclude that the observations
regarding high prevalence of ESBL-producers among P.
aeruginosa strains made in these studies as well as ours
might have been simply matters of coincidence. Class1
integrons are the most commonly found integron type in
Gram-negative bacteria [38]. Accordingly, we detected 7
class1 integrons all of which were invariably PCR-positive
for int1 and sul1. None of the blaCTX-M-15 markers were
found to be located within the integrons. Hence, it is
confirmed that the horizontal transfer of these markers
was not integron-mediated but whole plasmid-mediated
in our setting. Authors have earlier reported whole plas-
mid-mediated transfer of blaCTX-M-15 despite the pre-
sence of integron [39]. Transconjugation experiments
were successful in case of both the blaCTX-M-15 positive
E. coli strains in the present study. It is important to
mention here that in medical literature, not all transfer
experiments were successful with ESBL-producing E. coli.
In a study, 19 of 24 strains did not transfer the ESBLs
[40]. Similarly only 38% success was attained in transfer
of markers by conjugation in another study [41]. The
presence of strains co-resistant to aminoglycosides, qui-
nolones and third generation cephalosporins as observed
in our setting is a matter of due concern. Such strains if
combined with the production of carbapenemase might
result in therapeutic dead-ends [42,43].
This is the first study to report modeling of CTX-M-15
enzyme which is one of the most common ESBLs in India
and its docking with cefotaxime. Moreover, there is no
entry for CTX-M-15 in the Protein Data Bank to date.
Residues specifically in the active site omega loop (position
161-179) of CTX-M enzymes play an important role in the
substrate profile for cephalosporins [44]. But residues out-
side the omega loop might also help in fixing cefotaxime
into the active site of the enzyme, such as Asn-132 [45].
Accordingly we found that the residues Asn132, Glu166,
Pro167, Val172, Lys234 and Thr235 make important con-
tacts with cefotaxime in the docked complex. The SDN
(positions 130-132), and KTG (positions 234-236)
sequences, were found to be conserved, which are typical
structure of class A enzymes [46]. The sequences harbored
the D240G mutation with respect to CTX-M-3, the distin-
g u i s h i n gf e a t u r eo fC T X - M - 1 5e n z y m e s .N o n eo ft h e
mutations obtained in our CTX-M-15 sequences lied
within the omega loop or other positions that are known
to affect catalytic properties or substrate profile of these
enzymes. Hence the MIC values for cefotaxime and cefta-
zidime antibiotics in these isolates were typical of CTX-
M-15 producers (Table 2). The blaCTX-M-15 positive iso-
lates displayed cefotaxime MICs up to 8 fold higher than
ceftazidime MICs. The strain having a higher cefotaxime
MIC displayed a higher negative binding energy as well
(Table 1). It can be explained by the fact that a higher
negative value of binding energy for the enzyme-antibiotic
complex is an indicator of more stable and effective bind-
ing. A more stable and better fitting of the b-lactam anti-
biotic (cefotaxime) into the active site of the CTX-M-15
enzyme would ensure an easy hydrolysis of the drug. This
is in coherence with one of our earlier observations in
which we performed docking of the enzyme Sme1 with
different carbapenems to compare their effectiveness
against Sme1 producing bacteria [47]. It was observed that
the imipenem-Sme1 complex was far more stable than the
complex involving doripenem, the overall most effective
carbapenem to date. This suggested an easier hydrolysis of
imipenem by Sme-1 and a poor hydrolysis of doripenem.
Conclusions
The following conclusions can be drawn from this
study: (i) Male diabetic patients with MDRGNB-infected
foot ulcers have poor glycemic control and hence they
might have higher mortality rates compared to their
female counterparts (ii) Plasmid-mediated conjugal
transfer, albeit at a low frequency might be the possible
mechanism of transfer of blaCTX-M-15 resistance marker
in the present setting. (iii) Since the docking results
proved that the amino acid residues Asn132, Glu166,
Pro167, Val172, Lys234 and Thr235 of CTX-M-15
(enzyme) make important contacts with cefotaxime
(drug) in the ‘enzyme-drug complex’, researchers are
expected to duly utilize this information for designing
more potent and versatile CTX-M-inhibitors.
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